Investec Bank plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L), as required under Rule 8.5 of the Takeover Code.
The disclosure identifies Investec Bank as an exempt principal trader acting in a client-serving capacity with recognised intermediary status during the relevant dealing period.
Investec holds a significant advisory relationship with Advanced Medical Solutions Group, serving as both Advisor and Joint Broker to the company at the time of the disclosed transactions.
The dealings were undertaken on 24th July 2026, with the formal public disclosure submitted on 27th July 2026, in line with regulatory requirements.
According to the filing, Investec Bank purchased a total of 2,326,617 ordinary shares in Advanced Medical Solutions Group during the dealing period.
The purchases were executed at prices ranging from a low of 280 pence per unit to a high of 280.5 pence per unit across the transaction.
In addition to the purchases, Investec Bank also sold 2,125,336 ordinary shares, with prices ranging between 280 and 280.5 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or other formal or informal understandings that could constitute an inducement to deal or refrain from dealing.
The bank also confirmed no agreements or understandings exist relating to voting rights, future acquisitions, or disposals tied to any derivatives referencing the relevant securities.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure full market transparency.
The contact named in the disclosure is Priyali Bhattacharjee, and the filing falls under the oversight framework administered by the Takeover Panel’s Market Surveillance Unit.
